First-line pembrolizumab in advanced urothelial carcinoma: Clinical parameters associated with efficacy in the phase 2 KEYNOTE-052 and phase 3 KEYNOTE-361 trials.

Csoszi T., Powles T., Alva A. S., Castellano D. E., Ozguroglu M., O'Donnell P. H., ...More

JOURNAL OF CLINICAL ONCOLOGY, vol.40, no.6, 2022 (SCI-Expanded) identifier

  • Publication Type: Article / Abstract
  • Volume: 40 Issue: 6
  • Publication Date: 2022
  • Doi Number: 10.1200/jco.2022.40.6_suppl.521
  • Journal Name: JOURNAL OF CLINICAL ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, EMBASE, Gender Studies Database, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database
  • Istanbul University Affiliated: Yes